| Name | polypeptide N-acetylgalactosaminyltransferase 17 |
| Description | This gene encodes an N-acetylgalactosaminyltransferase. This gene is located centromeric to the common deleted region in Williams-Beuren syndrome (WBS), a multisystem developmental disorder caused by the deletion of contiguous genes at 7q11.23. This protein may play a role in membrane trafficking. [provided by RefSeq, Jan 2013] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n GALNT17, also known as WBSCR17 because of its location within the Williams‐Beuren syndrome critical region, is a member of the large UDP‐GalNAc:polypeptide N‐acetylgalactosaminyltransferase family responsible for initiating mucin‐type O‐glycosylation. Although its activity toward conventional mucin peptide substrates may be low in vitro, functional studies point to an important regulatory role in modulating cell surface glycosylation. For example, knockdown experiments have demonstrated that reduced GALNT17 expression leads to impaired lamellipodium formation, altered O‐glycan profiles, and increased macropinocytosis—implicating this enzyme in the dynamic control of membrane trafficking and endocytic processes in response to extracellular cues and nutrient levels."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond its cell biological functions, genetic analyses have linked GALNT17 to neurodevelopmental regulation. Imprinting and maternal genetic effect studies in autism spectrum disorder cohorts have identified aberrations at the GALNT17 locus, suggesting that dysregulation of its glycosylation activity may contribute to altered neural differentiation and connectivity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Additionally, single nucleotide variants in GALNT17 have been associated with metabolic traits and even with age‐related cataract risk in the context of lactose and galactose metabolism, indicating potential broader metabolic impacts of its function."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, by residing in the Williams–Beuren syndrome deletion region, GALNT17 is a candidate for contributing to the complex phenotype seen in this developmental disorder, where deficits in protein glycosylation may affect multiple organ systems."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " Collectively, these findings portray GALNT17 as a multifaceted modulator of O‐glycosylation that influences cytoskeletal dynamics, membrane trafficking, neurodevelopment, and metabolic processes.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yoshiaki Nakayama, Naosuke Nakamura, Sayoko Oki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A putative polypeptide N-acetylgalactosaminyltransferase/Williams-Beuren syndrome chromosome region 17 (WBSCR17) regulates lamellipodium formation and macropinocytosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.370932"}], "href": "https://doi.org/10.1074/jbc.M112.370932"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22787146"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22787146"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Siobhan Connolly, Richard Anney, Louise Gallagher, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A genome-wide investigation into parent-of-origin effects in autism spectrum disorder identifies previously associated genes including SHANK3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Hum Genet (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ejhg.2016.153"}], "href": "https://doi.org/10.1038/ejhg.2016.153"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27876814"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27876814"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Donghyun Jee, Suna Kang, Sunmin Park "}, {"type": "b", "children": [{"type": "t", "text": "Association of Age-Related Cataract Risk with High Polygenetic Risk Scores Involved in Galactose-Related Metabolism and Dietary Interactions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lifestyle Genom (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000521548"}], "href": "https://doi.org/10.1159/000521548"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34954695"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34954695"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Giuseppe Merla, Catherine Ucla, Michel Guipponi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of additional transcripts in the Williams-Beuren syndrome critical region."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Genet (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00439-002-0710-x"}], "href": "https://doi.org/10.1007/s00439-002-0710-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12073013"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12073013"}]}]}]}
|
| NCBI Gene ID | 64409 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
GALNT17 has 1,386 functional associations with biological entities spanning 5 categories (functional term, phrase or reference, chemical, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 25 datasets.
Click the + buttons to view associations for GALNT17 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of GALNT17 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with GALNT17 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of GALNT17 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing GALNT17 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with GALNT17 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for GALNT17 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with GALNT17 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with GALNT17 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving GALNT17 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of GALNT17 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with GALNT17 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with GALNT17 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by GALNT17 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of GALNT17 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of GALNT17 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| KEGG Pathways 2026 | pathways involving GALNT17 protein from the KEGG Pathways 2026 dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of GALNT17 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving GALNT17 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving GALNT17 protein from the Reactome Pathways 2024 dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of GALNT17 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of GALNT17 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of GALNT17 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of GALNT17 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of GALNT17 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with GALNT17 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |